BIT 6.67% 3.2¢ biotron limited

bioshares writeup

  1. 10,009 Posts.
    BIOSHARES did a long article on pharmasset today, they think the recent $11bn sale rates well for BIT. And that BIT still has a lot of potential , after some more trials .

    That's for you Sav.


    2 x 90 days trials mentioned, toxicology first and then with Ribovarin and maybe boceprivir.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $27.06M
Open High Low Value Volume
3.1¢ 3.2¢ 3.1¢ $2.205K 70.33K

Buyers (Bids)

No. Vol. Price($)
1 230405 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 828 1
View Market Depth
Last trade - 10.34am 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.